此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

评估计算机辅助检测在筛查性结肠镜检查中降低3年内进展期腺瘤风险的随机对照试验。 (IA-COLO 2)

2026年9月23日 更新者:University Hospital, Bordeaux

评估计算机辅助诊断在筛查性结肠镜检查中降低3年内进展期腺瘤风险的随机对照试验。

The occurrence of interval cancers after colonoscopy raises the possibility of missed lesions. High- performance computer aided diagnosis (CAD) systems have been specially designed for the detection of colorectal lesions (CAD for detection is named CADe). The use of CADe improves adenoma detection in screening colonoscopy. The potential of CADe system in reducing the rate of progression to advanced polyps or interval cancer between two colonoscopies remains still uncertain.

研究概览

详细说明

Patients will be enrolled after a pre-colonoscopy consultation and risk-assessment for colorectal cancer. The screening colonoscopy will be performed by an investigator. Patients will be randomized in the endoscopy room after confirmed cecal intubation and quality of bowel preparation. Randomization into two groups: standard colonoscopy vs. colonoscopy with CADe (CAD EYE or GENIUS) (1:1). A follow-up consultation will be scheduled one-month postcolonoscopy for delivery of histological results and then at 3 years in order to organize the next colonoscopy. As part of the study, a new control colonoscopy will be scheduled for patients with high risk of CRC at 3 years. The 3-year control colonoscopy will be performed with the CAD system for all patients. The colonoscopy will be performed by another investigator who does not know the results nor the type of the first colonoscopy (evaluator blinded). In the low-risk group, we will collect follow-up data as part of routine care, including the results of colonoscopies performed outside of the protocol

研究类型

介入性

注册 (估计的)

592

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

      • Bayonne、法国、64100
        • 尚未招聘
        • CH de la Côte Basque
        • 接触:
        • 首席研究员:
          • Félix GOUTORBE, MD
      • Brest、法国、29200
        • 尚未招聘
        • CHU Brest la Cavale Blanche
        • 接触:
        • 首席研究员:
          • Lucille QUENEHERVE, MD
      • Carhaix-Plouguer、法国、29270
      • Charenton-le-Pont、法国、94220
        • 尚未招聘
        • Clinique Paris Bercy
        • 接触:
        • 首席研究员:
          • David KARSENTI, MD
      • Limoges、法国、87042
        • 尚未招聘
        • CHU de Limoges
        • 接触:
        • 首席研究员:
          • Rémi COLLIN, MD
      • Marseille、法国、13009
        • 尚未招聘
        • Institut Paoli Calmettes
        • 首席研究员:
          • Jean-Philippe RATONE, MD
        • 接触:
      • Nantes、法国、44300
        • 尚未招聘
        • Clinique Jules Verne
        • 接触:
        • 首席研究员:
          • Bertrand BRIEAU, MD
      • Nîmes、法国、30029
        • 尚未招聘
        • CHU Nîmes
        • 首席研究员:
          • Ludovic CAILLO, MD
        • 接触:
      • Paris、法国、75020
        • 尚未招聘
        • APHP - Hôpital Tenon
        • 接触:
        • 首席研究员:
          • Antoine GUILLOUX, MD
      • Paris、法国、75015
        • 尚未招聘
        • Aphp-Hegp
        • 接触:
        • 首席研究员:
          • Guillaume PERROD, MD
      • Paris、法国、75012
        • 尚未招聘
        • APHP - Hôpital Saint Antoine
        • 接触:
        • 首席研究员:
          • Xavier DRAY, MD
      • Pessac、法国、33604
        • 招聘中
        • CHU Bordeaux - Hôpital Haut Lévêque
        • 首席研究员:
          • Arthur BERGER, MD
        • 接触:
      • Rennes、法国、35000
        • 尚未招聘
        • CHU de Rennes
        • 首席研究员:
          • Timothée WALLENHORST, MD
        • 接触:
      • Toulouse、法国、31076
        • 尚未招聘
        • Clinique Pasteur
        • 接触:
        • 首席研究员:
          • Mathieu GUIVARCH, MD
      • Vandœuvre-lès-Nancy、法国、54511
        • 尚未招聘
        • CHRU de Nancy - Hôpital Brabois Adultes
        • 接触:
        • 首席研究员:
          • Marion SCHAEFER, MD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Patients over 18 years of age with indication for colonoscopy as part of a screening program, after a positive immunological (FIT) test, and/or for personal or family history of colorectal cancer and/or personal history of colonic adenomas and/or sessile serrated polyp,
  • Written informed consent signed
  • Patients covered by a health-care insurance.

Exclusion Criteria:

  • Failed complete colonoscopy, defined by the absence of cecal intubation or identification of the terminal ileum.
  • Inadequate bowel preparation (Boston bowel preparation score < 6, and/or least at one part of colon with score ≤ 1)
  • An infiltrative tumor was diagnosed during colonoscope insertion time, not accessible to endoscopic resection and likely to require surgical management (a procedure where part of the colon may need to be removed).
  • Patient under guardianship or protection
  • Pregnant women
  • Not fluent in French or illiterate
  • Personal history of inflammatory bowel disease
  • Personal history of genetic predisposition of CRC
  • Personal history of major colorectal surgery involving total or subtotal colectomy

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:诊断
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
安慰剂比较:Standard colonoscopy

Patients will be enrolled after a pre-colonoscopy consultation and risk-assessment for colorectal cancer. The screening colonoscopy will be performed by an investigator. Patients will be randomized in the endoscopy room after confirmed cecal intubation and quality of bowel preparation. Patient has standard colonoscopy

Colonoscopy standard (without CADe)

有源比较器:Colonoscopy with CADe

Patients will be enrolled after a pre-colonoscopy consultation and risk-assessment for colorectal cancer. The screening colonoscopy will be performed by an investigator. Patients will be randomized in the endoscopy room after confirmed cecal intubation and quality of bowel preparation. Patient has colonoscopy with CADe (CAD EYE or GENIUS)

colonoscopy with CADe

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Advanced adenoma
大体时间:36 months

The proportion of patients presenting at least one advanced adenoma detected after a 3-year follow-up period. An advanced adenoma is defined as an adenoma or sessile serrate adenoma (SSL) larger than 1cm (size confirmed by the CAD system and/or size estimation by snare), and/or with high-grade dysplasia or neoplasia (confirmed by histological analysis).

36 months

次要结果测量

结果测量
措施说明
大体时间
Number of adenoma
大体时间:36 months

Average number of adenoma or SSL (confirmed by histological analysis) detected in each patient during screening colonoscopy after a 3-year follow-up period

36 months
Estimation of the sensitivity of CADx
大体时间:Day0, 36 months

Estimated sensitivity of CADx (CAD for characterization is named CADx) for the diagnosis and evaluation of colonic polyp's malignancy, with histologic analysis in each center as a reference diagnosis.

Day0, 36 months
Estimation of the specificity of CADx
大体时间:DAY 0, 36 months

Estimated specificity of CADx (CAD for characterization is named CADx) for the diagnosis and evaluation of colonic polyp's malignancy, with histologic analysis in each center as a reference diagnosis.

DAY 0, 36 months
Cost of CADe and classical colonoscopy
大体时间:Day 0, 36 months

The cost of CADe and classical colonoscopy will be estimated using a bottom-up micro costing approach

Day 0, 36 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年3月13日

初级完成 (估计的)

2031年3月1日

研究完成 (估计的)

2031年3月1日

研究注册日期

首次提交

2025年12月9日

首先提交符合 QC 标准的

2025年12月9日

首次发布 (实际的)

2025年12月23日

研究记录更新

最后更新发布 (实际的)

2026年9月24日

上次提交的符合 QC 标准的更新

2026年9月23日

最后验证

2026年3月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅